Overview of Device Regulations David Arvelo Small Business Representative.

Slides:



Advertisements
Similar presentations
Challenges in Using a Formal Decision Analysis Approach to Medical Device Approval Larry Kessler, Sc.D. Director, Office of Science and Engineering Laboratories.
Advertisements

BME-IDEA Workshop, September 28, 2005
Regulatory Pathway for Platform Technologies
Entering the US Market: Medical Devices
Overview of FDA Device Regulations
Replacement Reagent Policy Update
"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
AXENDIA  Bringing Medical Devices to the Market Bringing Medical Devices to the Market Paths and Pitfalls By Daniel R. Matlis and David J. Lennard February.
Pinhas (Peter) Dartal 01 June QA role in development of Percutaneous Aortic Valve prosthesis.
Development of ISO standards for AD syringes SIGN Meeting Cambodia, October 2002 Injection technologies G Gerald Verollet.
510k Submission Overview Myraqa, Inc. August 22, 2012.
Snoring and Obstructive Sleep Apnea (OSA) Devices Dental Devices Branch Division of Anesthesiology, General Hospital, Infection Control and Dental Devices.
Agenda The role of MHRA, Hospitals and the Manufacturer
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.
Accelerating Product Development June 25, 2015 IMDMC REG 101 Pathways To Market.
Medical Devices Approval Process
Entering the North American Market
Total Product Life Cycle An Example. Medcon May 2, Agenda Post Market Surveillance Total Product Life Cycle and Product Design Systematic Collection.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
CE marking Catriona Blake Team Manager, Imaging, acute and community care.
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Medical Device Revisions Case Study Phil Brown 20th September 2012.
Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.
Unique Device Identification and Global Medical Device Nomenclature Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
1 Unique Device Identification (UDI) – Enabling the Transformation of Medical Device Safety Terrie Reed, MSIE Associate Director, Informatics
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
FDA MedWatch and Patient Safety. Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006  The Act defines a ‘serious adverse event’
Life cycle of medical devices Gerald Verollet World Health Organization 3rd SIGN Meeting - New Delhi.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Cellular Products for Cardiac Diseases Dwaine Rieves, MD Center for Biologics Evaluation and Research FDA Perspective on:
What Makes a Good Medical Device Adverse Event Report?
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
1 Medical Device Registries: Multiple Applications Thomas P. Gross, MD, MPH Director Division of Postmarket Surveillance Office of Surveillance & Biometrics.
Development and Regulation of Medical Products (MEDR-101)
Clinical Experience With the EX-PRESS ® Glaucoma Filtration Device Thomas W. Samuelson, M.D. Minnesota Eye Consultants Minneapolis EXP11748SK.
Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.
FDA Focus On Consumer Protection
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
FDA’s Draft LDT Framework & Personalized Medicine Update
Drug Safety and Risk Management Advisory Committee May 18-19, Overview of Drug Safety Challenges Gerald J. Dal Pan, MD, MHS Director Division of.
1 CDRH: Minimizing Risk of TSE Agents in Medical Devices CDR Martha O’Lone, RN, BSN CDRH TSE Working Group Chair Infection Control Devices Branch DAGID.
FDLI Introduction to Medical Device Law and Regulation Other Postmarket Controls Philip Katz (202) October 29, 2002 Washington,
History of Pediatric Labeling
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
Labeling and Electronic Initiatives Rachel E. Behrman M.D., M.P.H. Deputy Director, Office of Medical Policy CDER FDA Science Board, April 15, 2005.
REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR
Overview of Medical Devices Regulations Velocity Science Sarah Chandler A/Manager, Device Licensing Services Division Medical Devices Bureau Health Canada.
GU Advisory Panel Meeting Nocturnal Home Hemodialysis Draft Carolyn Y. Neuland, Ph.D. Chief, Gastroenterology and Renal Devices Branch Division of Reproductive,
TF_Arusha_Jun10/1 Framework for Evaluation of Male Circumcision Devices Tim Farley Department of Reproductive Health and Research World Health Organization.
Moj Eram, PhD Senior Consultant ARC Experts, LLC 6 April, 2016
Regulation of Medical Devices: Tanzania experience Fimbo, A. M Tanzania Food and Drugs Authority.
INTRODUCTION Medical Devices ©2014 Salt Lake Community College. All rights reserved.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
Dental Standards & Testing Methods
Postmarket Assessment in the U.S. and Unique Device Identifiers (UDI)
Division of Cardiovascular Devices
Premarket Notification 510(k) process
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
FDA-CDRH in the Next Decade A Vision for Change
HOW TO FULFILL STATUTORY REQUIREMENTS ON PRODUCT RELATED HEALTH INFORMATION Samina Qureshi, M.D. PSI INTERNATIONAL Inc.
Snoring and Obstructive Sleep Apnea (OSA) Devices
Labeling and Electronic Initiatives
digital FDA Bakul Patel
Presentation transcript:

Overview of Device Regulations David Arvelo Small Business Representative

2 Total Product Life Cycle

3 Device Classification System Increases with level of risk Class I Class II Class III Determines level of regulation applied to the device

4 Class I Devices 46% of all devices Low-risk devices Surgical instruments, wound dressings, toothbrush General Controls Most are exempt from Premarket Notification, 510(k)

5 General Controls Establishment Registration Medical Device Listing Good Manufacturing Practice (Quality System Regulation) Device labeling Premarket proof of safety and effectiveness, i.e., 510(k)

6 Class II Devices 47% of all devices Moderate-risk devices E.g., blood pressure cuffs, vascular clamps, sutures, aneurysm clips, oximeters, urology catheters, cautery devices General and Special Controls Most not exempt from Premarket Notification, 510(k)

7 Special Controls Performance standards Guidance documents Clinical data, special labeling, warnings, precautions, contraindications Postmarket surveillance Patient registries Tracking, Adverse Events

8 Class III Devices <10% of all devices Moderate and high risk devices Pacemakers, breast implants, vascular grafts, lithotripters, lasers General Controls, Special Controls, and Premarket Approval (PMA) Clinical data needed (IDE)

9 Device Categories 1746 Categories 786 Class I 729 exempt from 510(k) 860 Class II 68 exempt from 510(k) 100 Class III

10

11 Quality System Guidance Medical Device Quality Systems Manual: A Small Entity Compliance Guide FDA Available free online at

12

13 DSMICA Division of Small Manufacturers, International, and Consumer Assistance Device Advice CDRH Learn CDRH Databases Toll-free in the USA

14 Office of Combination Products FDA assistance and guidance for manufacturers of drug/device/biologic combination medical products Phone Fax

15 My Contact Information David Arvelo, SBR FDA/ORA/SWRO (HFR-SW2) 4040 N. Central Expressway Suite 900 Dallas, TX Telephone Fax